Clinical Trials Browser

Completed × OTHER × G250 monoclonal antibody × Clear all

NCT02883153 2017-06-19

Zirconium-89-girentuximab PET/CT Imaging in Renal Cell Carcinoma

Phase 2/3 Completed

Carcinoma, Renal Cell

NCT00602862 2013-12-02

Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250

Phase NA Completed

Carcinoma, Renal Cell